NGSベースのRNA-seqの世界市場 2023-2027

当レポートではNGSベースのRNA-seqの市場規模は、2023年から2027年の間に37億5373万米ドルの増加が見込まれ、予測期間中に15.34%のCAGRで成長すると予測しています。当レポートでは、NGSベースのRNA-seq市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。

市場は、次世代シーケンシング手法の採用の増加、シーケンシングプラットフォームの技術的進歩、幅広い次世代シーケンシング製品の入手が可能であることなどが原動力となっています。

本調査では、次世代シーケンサー技術の進歩が、今後数年間のNGSベースのRNA-seq市場の成長を促進する主要な理由の1つであると特定しています。また、遺伝子配列決定のコスト削減、バイオインフォマティクスとクラウドベースのソフトウェアプログラムの分野での開拓が、市場での大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界のNGSベースのRNA-seq市場2017年～2021年
• エンドユーザー別セグメント分析2017-2021
• テクノロジー別セグメント分析2017-2021
• 地域別セグメント分析2017-2021
• 国別セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 エンドユーザー別市場セグメンテーション

• 市場内訳
• エンドユーザー別比較
• 学術および研究センター - 市場規模と予測 2022-2027
• 臨床調査 - 市場規模と予測 2022-2027
• 製薬会社 - 市場規模と予測 2022-2027
• 病院 - 市場規模と予測 2022-2027
• エンドユーザー別の市場機会

第7章 テクノロジー別市場セグメンテーション

• 市場内訳
• 技術別比較
• 合成別配列決定 - 市場規模と予測 2022-2027
• イオン半導体シーケンシング - 市場規模と予測 2022-2027
• 単一分子リアルタイムシーケンシング - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• テクノロジー別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• シンガポール - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Agilent Technologies Inc.
• BGI Genomics Co. Ltd.
• Brooks Automation Inc.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Hamilton Bonaduz AG
• Illumina Inc.
• Pacific Biosciences of California Inc.
• PerkinElmer Inc.
• Psomagen Inc.
• QIAGEN NV
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Zymo Research Corp.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on End-user - Market share 2022-2027 (%)
• Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by End-user ($ million)
• Exhibits51: Chart on Technology - Market share 2022-2027 (%)
• Exhibits52: Data Table on Technology - Market share 2022-2027 (%)
• Exhibits53: Chart on Comparison by Technology
• Exhibits54: Data Table on Comparison by Technology
• Exhibits55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
• Exhibits56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
• Exhibits58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
• Exhibits59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits71: Market opportunity by Technology ($ million)
• Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits75: Chart on Geographic comparison
• Exhibits76: Data Table on Geographic comparison
• Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
• Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits113: Market opportunity By Geographical Landscape ($ million)
• Exhibits114: Impact of drivers and challenges in 2022 and 2027
• Exhibits115: Overview on Criticality of inputs and Factors of differentiation
• Exhibits116: Overview on factors of disruption
• Exhibits117: Impact of key risks on business
• Exhibits118: Vendors covered
• Exhibits119: Matrix on vendor position and classification
• Exhibits120: Agilent Technologies Inc. - Overview
• Exhibits121: Agilent Technologies Inc. - Business segments
• Exhibits122: Agilent Technologies Inc. - Key news
• Exhibits123: Agilent Technologies Inc. - Key offerings
• Exhibits124: Agilent Technologies Inc. - Segment focus
• Exhibits125: BGI Genomics Co. Ltd. - Overview
• Exhibits126: BGI Genomics Co. Ltd. - Product / Service
• Exhibits127: BGI Genomics Co. Ltd. - Key offerings
• Exhibits128: Brooks Automation Inc. - Overview
• Exhibits129: Brooks Automation Inc. - Business segments
• Exhibits130: Brooks Automation Inc. - Key offerings
• Exhibits131: Brooks Automation Inc. - Segment focus
• Exhibits132: Eurofins Scientific SE - Overview
• Exhibits133: Eurofins Scientific SE - Business segments
• Exhibits134: Eurofins Scientific SE - Key news
• Exhibits135: Eurofins Scientific SE - Key offerings
• Exhibits136: Eurofins Scientific SE - Segment focus
• Exhibits137: F. Hoffmann La Roche Ltd. - Overview
• Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits139: F. Hoffmann La Roche Ltd. - Key news
• Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits142: Hamilton Bonaduz AG - Overview
• Exhibits143: Hamilton Bonaduz AG - Product / Service
• Exhibits144: Hamilton Bonaduz AG - Key offerings
• Exhibits145: Illumina Inc. - Overview
• Exhibits146: Illumina Inc. - Business segments
• Exhibits147: Illumina Inc. - Key news
• Exhibits148: Illumina Inc. - Key offerings
• Exhibits149: Illumina Inc. - Segment focus
• Exhibits150: Pacific Biosciences of California Inc. - Overview
• Exhibits151: Pacific Biosciences of California Inc. - Product / Service
• Exhibits152: Pacific Biosciences of California Inc. - Key offerings
• Exhibits153: PerkinElmer Inc. - Overview
• Exhibits154: PerkinElmer Inc. - Business segments
• Exhibits155: PerkinElmer Inc. - Key news
• Exhibits156: PerkinElmer Inc. - Key offerings
• Exhibits157: PerkinElmer Inc. - Segment focus
• Exhibits158: Psomagen Inc. - Overview
• Exhibits159: Psomagen Inc. - Product / Service
• Exhibits160: Psomagen Inc. - Key offerings
• Exhibits161: QIAGEN NV - Overview
• Exhibits162: QIAGEN NV - Product / Service
• Exhibits163: QIAGEN NV - Key news
• Exhibits164: QIAGEN NV - Key offerings
• Exhibits165: Takara Bio Inc. - Overview
• Exhibits166: Takara Bio Inc. - Product / Service
• Exhibits167: Takara Bio Inc. - Key offerings
• Exhibits168: Tecan Trading AG - Overview
• Exhibits169: Tecan Trading AG - Business segments
• Exhibits170: Tecan Trading AG - Key offerings
• Exhibits171: Tecan Trading AG - Segment focus
• Exhibits172: Thermo Fisher Scientific Inc. - Overview
• Exhibits173: Thermo Fisher Scientific Inc. - Business segments
• Exhibits174: Thermo Fisher Scientific Inc. - Key news
• Exhibits175: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits176: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits177: Zymo Research Corp. - Overview
• Exhibits178: Zymo Research Corp. - Product / Service
• Exhibits179: Zymo Research Corp. - Key offerings
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Validation techniques employed for market sizing
• Exhibits185: Information sources
• Exhibits186: List of abbreviations

Technavio has been monitoring the NGS-based RNA-seq market and it is poised to grow by $3,753.73 mn during 2023-2027, accelerating at a CAGR of 15.34% during the forecast period. Our report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of next-generation sequencing methods, technological advancement in sequencing platforms, and the availability of wide range of next generation sequencing products.

Technavio's NGS-based RNA-seq market is segmented as below:

By End-user

• Academic and research centers
• Clinical research
• Pharma companies
• Hospitals

By Technology

• Sequencing by synthesis
• Ion semiconductor sequencing
• Single-molecule real-time sequencing
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the NGS-based RNA-seq market covers the following areas:

• NGS-based RNA-seq market sizing
• NGS-based RNA-seq market forecast
• NGS-based RNA-seq market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Brooks Automation Inc., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Precigen Inc., Pacific Biosciences of California Inc., PerkinElmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global NGS-based RNA-seq market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
• 4.2 End User Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
• 4.3 Technology Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Acamedic and research centers - Market size and forecast 2022-2027
• Exhibit 34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
• 6.4 Clinical research - Market size and forecast 2022-2027
• Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
• 6.5 Pharma companies - Market size and forecast 2022-2027
• Exhibit 42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
• 6.6 Hospitals - Market size and forecast 2022-2027
• Exhibit 46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by End-user
• Exhibit 50: Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
• Exhibit 51: Chart on Technology - Market share 2022-2027 (%)
• Exhibit 52: Data Table on Technology - Market share 2022-2027 (%)
• 7.2 Comparison by Technology
• Exhibit 53: Chart on Comparison by Technology
• Exhibit 54: Data Table on Comparison by Technology
• 7.3 Sequencing by synthesis - Market size and forecast 2022-2027
• Exhibit 55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
• 7.4 Ion semiconductor sequencing - Market size and forecast 2022-2027
• Exhibit 59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
• 7.5 Single-molecule real-time sequencing - Market size and forecast 2022-2027
• Exhibit 63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Technology
• Exhibit 71: Market opportunity by Technology ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 75: Chart on Geographic comparison
• Exhibit 76: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Singapore - Market size and forecast 2022-2027
• Exhibit 105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 113: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 114: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 116: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 117: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 118: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 119: Matrix on vendor position and classification
• 12.3 Agilent Technologies Inc.
• Exhibit 120: Agilent Technologies Inc. - Overview
• Exhibit 121: Agilent Technologies Inc. - Business segments
• Exhibit 122: Agilent Technologies Inc. - Key news
• Exhibit 123: Agilent Technologies Inc. - Key offerings
• Exhibit 124: Agilent Technologies Inc. - Segment focus
• 12.4 BGI Genomics Co. Ltd.
• Exhibit 125: BGI Genomics Co. Ltd. - Overview
• Exhibit 126: BGI Genomics Co. Ltd. - Product / Service
• Exhibit 127: BGI Genomics Co. Ltd. - Key offerings
• 12.5 Brooks Automation Inc.
• Exhibit 128: Brooks Automation Inc. - Overview
• Exhibit 129: Brooks Automation Inc. - Business segments
• Exhibit 130: Brooks Automation Inc. - Key offerings
• Exhibit 131: Brooks Automation Inc. - Segment focus
• 12.6 Eurofins Scientific SE
• Exhibit 132: Eurofins Scientific SE - Overview
• Exhibit 133: Eurofins Scientific SE - Business segments
• Exhibit 134: Eurofins Scientific SE - Key news
• Exhibit 135: Eurofins Scientific SE - Key offerings
• Exhibit 136: Eurofins Scientific SE - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Hamilton Bonaduz AG
• Exhibit 142: Hamilton Bonaduz AG - Overview
• Exhibit 143: Hamilton Bonaduz AG - Product / Service
• Exhibit 144: Hamilton Bonaduz AG - Key offerings
• 12.9 Illumina Inc.
• Exhibit 145: Illumina Inc. - Overview
• Exhibit 146: Illumina Inc. - Business segments
• Exhibit 147: Illumina Inc. - Key news
• Exhibit 148: Illumina Inc. - Key offerings
• Exhibit 149: Illumina Inc. - Segment focus
• 12.10 Pacific Biosciences of California Inc.
• Exhibit 150: Pacific Biosciences of California Inc. - Overview
• Exhibit 151: Pacific Biosciences of California Inc. - Product / Service
• Exhibit 152: Pacific Biosciences of California Inc. - Key offerings
• 12.11 PerkinElmer Inc.
• Exhibit 153: PerkinElmer Inc. - Overview
• Exhibit 154: PerkinElmer Inc. - Business segments
• Exhibit 155: PerkinElmer Inc. - Key news
• Exhibit 156: PerkinElmer Inc. - Key offerings
• Exhibit 157: PerkinElmer Inc. - Segment focus
• 12.12 Psomagen Inc.
• Exhibit 158: Psomagen Inc. - Overview
• Exhibit 159: Psomagen Inc. - Product / Service
• Exhibit 160: Psomagen Inc. - Key offerings
• 12.13 QIAGEN NV
• Exhibit 161: QIAGEN NV - Overview
• Exhibit 162: QIAGEN NV - Product / Service
• Exhibit 163: QIAGEN NV - Key news
• Exhibit 164: QIAGEN NV - Key offerings
• 12.14 Takara Bio Inc.
• Exhibit 165: Takara Bio Inc. - Overview
• Exhibit 166: Takara Bio Inc. - Product / Service
• Exhibit 167: Takara Bio Inc. - Key offerings
• 12.15 Tecan Trading AG
• Exhibit 168: Tecan Trading AG - Overview
• Exhibit 169: Tecan Trading AG - Business segments
• Exhibit 170: Tecan Trading AG - Key offerings
• Exhibit 171: Tecan Trading AG - Segment focus
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 172: Thermo Fisher Scientific Inc. - Overview
• Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 174: Thermo Fisher Scientific Inc. - Key news
• Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Zymo Research Corp.
• Exhibit 177: Zymo Research Corp. - Overview
• Exhibit 178: Zymo Research Corp. - Product / Service
• Exhibit 179: Zymo Research Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 180: Inclusions checklist
• Exhibit 181: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 182: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 183: Research methodology
• Exhibit 184: Validation techniques employed for market sizing
• Exhibit 185: Information sources
• 13.5 List of abbreviations
• Exhibit 186: List of abbreviations